| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |